top of page
Lucid

Our DiaComp pilot grant was selected for funding

Our pilot award to DiaComp was selected for funding! The goal of this pilot study is to test novel podocyte protective compounds that emerged from a phenotypic screen in an animal model of diabetic kidney disease


10 views0 comments

Recent Posts

See All

The molecular mechanisms underlying nephrotic syndrome (NS) are unknown. In this three-way collaboration between Duke University (primary), University of Miami, and University of Michigan, we will exa

Our team is still growing! We are now seeking to hire a talented Research Associate to participate in several drug discovery projects. If you to want work in a positive and exciting research environme

Our grant application (Ali, Lemmon, Bixby, Lee, Arizala) to the Blueprint Neurotherapeutics network was selected for funding! The goal of this proposal is to generate a therapeutic candidate (spinal c

bottom of page